Geron Corporation (GERN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $606.81M
Last updated: Nov 17, 2026 at 4:32 PM ET
Geron Corporation (GERN) Stock Chart
Geron (GERN) has a latest price of $1.00 on Nov 17, 2026, 50.2% below its 52-week high of $2.01. Its price fell 10.7% over the past 12 months. The month-end price fell 51.7% over the 10 years through Oct 2026, a compound annual decline of 7.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $5.73 in Aug 2018 and its lowest $0.89 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GERN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GERN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 37.1%, and over 6 months it fell 18.0%. The month-end price fell 52.9% over the 3 years through Oct 2026, a compound annual decline of 22.2%.
| Period | Change |
|---|---|
| 1 month | -16.7% |
| 3 months | -37.1% |
| 6 months | -18.0% |
| 12 months | -10.7% |
| 12 months, with dividends | -10.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -52.9% | -22.2% |
| 5 years | -41.9% | -10.3% |
| 10 years | -51.7% | -7.0% |
Price by Year
Its best calendar year was 2022, when the price rose 98.4%, and its weakest was 2025, when it fell 62.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.89 | -32.2% |
| 2025 | $1.32 | -62.7% |
| 2024 | $3.54 | +67.8% |
| 2023 | $2.11 | -12.8% |
| 2022 | $2.42 | +98.4% |
| 2021 | $1.22 | -23.3% |
| 2020 | $1.59 | +16.9% |
| 2019 | $1.36 | +36.0% |
| 2018 | $1.00 | -44.4% |
| 2017 | $1.80 | -13.0% |
Trading Range
The price is 13.8% below its 50-day average of $1.16 and 28.7% below its 200-day average of $1.40.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.00 | |
| 52-week high | $2.01 | -50.2% |
| 52-week low | $0.84 | +19.0% |
| 50-day average | $1.16 | -13.8% |
| 200-day average | $1.40 | -28.7% |
Price Risk
Over 3 years, its largest fall from a peak was 82.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.42 |
| Largest fall, 1 year | -54.1% |
| Largest fall, 3 years | -82.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GERN
What is GERN's 1-year price change?
Geron's price fell 10.7% over the past 12 months. With dividends included, the 12-month total return was -10.7%.
What is GERN's 5-year price change?
Geron's month-end price fell 41.9% over the 5 years through Oct 2026, a compound annual decline of 10.3%. These figures leave out dividends.
What is GERN's 52-week high and low?
Geron's 52-week high is $2.01 and its 52-week low is $0.84. Its latest price of $1.00 on Nov 17, 2026 is 50.2% below the high.
What is GERN's beta?
Geron's 1-year beta against the S&P 500 is 1.42, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 54.1%.
Is the GERN chart free?
Yes. Advanced Charting for GERN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GERN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors